Search

23 Feb 2024: The Experimental Medicine and Immunotherapeutics division has a strong record in clinical research. ... Professor David Jayne : Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital.

23 Feb 2024: and Smith, K.G.C. “Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.” Annals of the Rheumatic Diseases, 2010;69:1208-1213. ... and Salama, A.D.

23 Feb 2024: Wellcome Trust Senior Investigator. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. ... FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted

22 Feb 2023: long-term value.”. Immune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common, chronic and incurable, and there is currently no way of knowing whether a patient is ... I’m delighted to welcome Paul to the team and

23 Feb 2024: Prof Andrew Grace, Department of Biochemistry, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust. - ... Prof David Jayne, Director of the Vasculitis and Lupus Service, Cambridge University Hospitals NHS Foundation Trust. -

uploads/2019/03/DavidJayne-HQ-819x1024.jpg 819w" sizes="(max-width: 240px) 100vw, 240px" //a/pnpClinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research

24 May 2013: David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus unit at Addenbrooke’s Hospital, Cambridge. ... biologic and other newer therapies in vasculitis, systemic lupus erythematosus and Behcet’s disease.

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

2 Jul 2024: PredictImmune and I’m honoured to have beenappointed to lead the company as it enters the commercialisation phase of its expansion. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Search site. Cambridge Immunology Network. Dr Luis F. Quintana. Biomarker studies in ANCA-associated vasculitis, lupus and immune-mediated renal disease. ... We perform state-of-the-art proteomic analyses on plasma and urine samples of patients with

26 Jun 2024: causing proteins within tumour cells and trigger pathways to eliminate these proteins, thereby halting further growth of the tumour. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: At the Department of Rheumatology, Lund University in Sweden, I am the PI of a comorbidity project addressing the frequencies and predictors of common morbidities in ANCA vasculitis and giant cell ... In June 2013, I joined a postdoctoral research

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

26 Jun 2024: Whilst lupus can be controlled through lifestyle changes and medical interventions, there is currently no cure. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common,

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Senior Lecturer Transfusion Medicine. Arthritis Research UK rheumatology lecturer. Wellcome-Beit Prize and Intermediate Clinical Fellow. ... 01223 762127. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

3 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Search site. Cambridge Immunology Network. Dr David Jayne. Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research vasculitis network (EUVAS) and